Skip to content
Friday, March 24, 2023
HealthCare Middle East & Africa Logo 500

No.1 Healthcare & Pharma Industry Magazine for Middle East & Africa

  • HOME
  • TOPICS
    • MERGERS, INVESTMENTS & FUNDING
    • DISEASES UPDATES
    • HOSPITALS
    • PHARMACEUTICALS
    • PEOPLE NEWS
  • THE MAGAZINE
    • About HealthCare Middle East & Africa Magazine
    • PRESS RELEASES
    • SUBSCRIBE TO EMAIL NEWSLETTERS
  • ADVERTISE
  • PROFILES & INTERVIEWS
  • OUR EVENTS
  • CONTACT US
BREAKING NEWS
  • UAE-based AstraGene and Mylab form joint venture to commercialize automated diagnostics
  • Chinese missionaries in Rwanda perform painless normal delivery
  • <strong>OSHCO, VAMED Group to establish a new rehabilitation & long-term care hospital in Riyadh</strong>
  • Uganda launches project to scale up paediatric surgical services in hospitals
  • <strong>Dubai’s state-owned DAHC, Pfizer, AXDEV Group ally to enhance chronic illness care</strong>
  • Macra supports Ministry of Health with US$53,296 cholera materials
  • KFSH&RC to debut its Digital Health Conference in Riyadh
  • NPHCDA launches project to prevent maternal health challenges
  • <strong>Saudi’s KAEC inks health cooperation pact with Dr. Sulaiman Al Habib Medical Group</strong>
  • Africa has the highest global surge in oral diseases - WHO
You are here
  • Home
  • Japan

Tag: Japan

Pharmacosmos expands global reach with launch of Monofer in Japanese market

20 March 202320 March 2023

JAPAN — Pharmacosmos, a pharmaceutical company based in Denmark, has announced the release of its intravenous treatment for iron deficiency anemia, Monofer (ferric derisomaltose), in Japan. The launch follows the…

Read More

Japan collaborates with Ministry of Health to reduce mortality of newborns

18 March 202318 March 2023

KENYA – The Ministry of Health is collaborating with Japanese engineers on a Vaccination Management System (VMS) that will include biometric technologies. This system aims to improve the survival rates…

Read More

Eisai’s sales projections for Leqembi exceed US$7 billion by 2030

13 March 202313 March 2023

JAPAN —Eisai has announced that its Alzheimer’s disease drug Leqembi (lecanemab), developed in partnership with Biogen, is expected to generate peak sales of JPY 1.2 trillion (US$7.4 billion) by the…

Read More

Takeda and Hutchmed tie up on cancer drug for US$1.13B

15 February 202315 February 2023

JAPAN — Takeda, a pharmaceutical company from Japan, has partnered with Hong Kong-based Hutchmed to gain commercial rights to the colorectal cancer drug fruquintinib outside of China for US$400 million,…

Read More

Takeda acquires Nimbus Therapeutics’ subsidiary for US$6B

14 February 202314 February 2023

JAPAN — Takeda has expanded its psoriasis treatment portfolio after completing its acquisition of the Nimbus Lakshmi program from Nimbus Therapeutics in a deal worth up to US$6 billion. Under…

Read More

Scientists develop new device to detect brain tumors using urine

13 February 202313 February 2023

JAPAN — Scientists from Nagoya University in Japan have developed a new device that detects a specific membrane protein in urine to determine if a patient has a brain tumor.…

Read More

Japanese firms join forces to reduce industry’s environmental footprint

6 February 20237 February 2023

JAPAN — The four biggest pharmaceutical companies in Japan, Astellas Pharma Inc., Eisai Co., Daiichi Sankyo Company, and Takeda Pharmaceutical have agreed to collaborate to reduce environmental burden in the…

Read More

UNICEF bags US$5.1M in funding from Japan to improve healthcare delivery in Syria

20 December 202220 December 2022

SYRIA – The United Nations Children’s Fund (UNICEF) has received US$5.1 million in funding from the Government of Japan to scale up delivery of quality healthcare in the Syrian Arab…

Read More

Takeda to pay up to US$6 billion for Nimbus’ mid-stage immune-therapy drug

14 December 202214 December 2022

JAPAN — Takeda Pharmaceutical has agreed to pay up to US$6 billion (813 billion) for an experimental immune therapy developed by Nimbus Therapeutics, as part of the Japanese pharmaceutical company’s…

Read More

Japan’s MHLW approves Daiichi Sankyo’s Enhertu for breast cancer treatment

27 November 202227 November 2022

JAPAN — The Japanese Ministry of Health, Labor, and Welfare (MHLW) has approved Daiichi Sankyo’s Enhertu (trastuzumab deruxtecan) for the treatment of adults with HER2-positive unresectable or recurrent breast cancer.…

Read More

Posts navigation

Older posts

LATEST DIGITAL MAGAZINE

LATEST NEWS

  • UAE-based AstraGene and Mylab form joint venture to commercialize automated diagnostics
  • Chinese missionaries in Rwanda perform painless normal delivery
  • OSHCO, VAMED Group to establish a new rehabilitation & long-term care hospital in Riyadh
  • Uganda launches project to scale up paediatric surgical services in hospitals
  • Dubai’s state-owned DAHC, Pfizer, AXDEV Group ally to enhance chronic illness care

MOST POPULAR TAGS

Africa Africa CDC Artificial Intelligence AstraZeneca Cancer Covid-19 Diabetes Digital health Egypt France Germany Ghana GSK Healthcare Delivery HIV/AIDS Hospitals India Japan Johnson & Johnson Kenya Malaria Merck Mergers, Investments & Funding Middle East and North Africa Moderna MOH Kenya Nigeria Novartis Partnerships Pfizer Pharmaceuticals Public Health Roche Science & Technology South Africa Switzerland Tanzania UAE Uganda UK UNICEF USA US FDA Vaccines WHO

ARCHIVES

ABOUT FW AFRICA

We organise some of the most impactful face to face and virtual trade events and publish leading magazines and websites that bring Africa to the World and the World to Africa. We believe that when people come together, networks grow and businesses thrive.

Find more about us on our corporate website www.fwafrica.net

RELATED PUBLICATIONS

CEO Business Africa

Food Business Africa

Food Safety Africa

Milling & Baking Africa

Sustainable Packaging Africa

CONTACT US

FW Africa

P.O. Box 1874-00621, Nairobi, Kenya

Tel: +254 725 34 39 32

Email: info@fwafrica.net

Copyright © All rights reserved. FW Africa. We are not responsible for content from external sites.